CIK 0001627281 · Accelerated filer
Cellectis S.A.
Sign in to watch- Ticker
- CLLS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- France
- Entity type
- other
- Phone
- 33181691600
- Business address
- 8 RUE DE LA CROIX JARRY, PARIS, LLE-DE-FRANCE, France
- S-8 POS Other Post-effective Amendment
- CT ORDER Other Confidential Order
- S-8 Other Securities Offered to Employees in Benefit Plans
- EFFECT Other Notice of Effectiveness
- F-3 Offering F-3
- RW Other RW
- S-8 Other Securities Offered to Employees in Benefit Plans
- CT ORDER Other Confidential Order
- F-3ASR Offering Registration Statement
- S-8 Other Securities Offered to Employees in Benefit Plans
- CT ORDER Other Confidential Order
- EFFECT Other Notice of Effectiveness
- EFFECT Other Notice of Effectiveness
- F-1MEF Other F-1MEF
- CERTNAS Other Certification by the Nasdaq Stock Market
- FWP Offering Free Writing Prospectus
- 8-A12B Other Registration of Securities
- F-6 Other Registration of American Depositary Receipt Shares
- DRS/A Other Draft Registration Statement
- DRSLTR Other Correspondence Related to Draft Registration Statement
Page 2 of 3 · 43 filings